This publication uses cookies

We use functional and analytical cookies to improve our website. In addition, third parties place tracking cookies to display personalised advertisements on social media. By clicking accept you consent to the placement of these cookies.
icon A

EDCTP portfolio: Clinical Research & Development Fellowships

watermark

The STReK project is enabling the University of Nairobi to strengthen the capacity of research ethics committees in Kenya.

Strengthening ethics review in Kenya

watermark

Research ethics committees are essential for reviewing clinical research proposals and ensuring that projects conform to high ethical standards. The growth of clinical research in sub-Saharan Africa, and increasing complexity in the range of ethical issues that need to be considered, is placing strains on many countries’ infrastructure for ethics review.

In Kenya, research ethics committees are accredited by the National Commission for Science, Technology and Innovation (NACOSTI), through its National Bioethics Committee. The number of accredited research ethics committees has increased from five in 2009 to 25 in 2018.

The challenge

watermark

Through the STReK project, the University of Nairobi is working in collaboration with NACOSTI and the National Bioethics Committee to improve the efficiency of the Committee and to strengthen the capacity of members of both the National Committee and institutional research ethics committees in the country to undertake ethics review.

The project has facilitated the development of a new strategic plan for the National Bioethics Committee, based on extensive consultation among stakeholders. To support more effective working and streamlining of its operations, the project has helped to develop a set of revised standard operating procedures for the National Bioethics Committee. These will provide templates for use by research ethics committees across the country.

With support from the STReK project, the National Bioethics Committee is also enhancing its IT infrastructure for monitoring research ethics committees and creating a database of committee members to support networking and consultation. 

A research ethics training package is being developed and will be delivered to at least 120 committee members. A structured mentorship programme is also being introduced, including placements at mentor sites, for 22 research ethics committee members. At the end of the project, NACOSTI will organise a research ethics conference to promote networking, sharing of experience and benchmarking, with invitations extended to other national bioethics committees in East Africa and at least one EU research ethics committee.

The project

watermark

The STReK project is strengthening connections between academia and a key regulatory body in Kenya, to improve the efficiency and quality of ethics review processes in the country. It will help to ensure that the country remains an attractive country in which to carry out clinical research and has the capacity to increase the volume of research undertaken.

Impact

icon A
icon B


test the safety and efficacy of this new formulation in young children

Bringing antiretroviral drugs to children

watermark

The CHAPAS trials have ensured that many more children with HIV have benefited
from life-saving antiretrovirals.

EDCTP portfolio: HIV & HIV-associated infections

The challenge

Research ethics committees are essential for reviewing clinical research proposals and ensuring that projects conform to high ethical standards. The growth of clinical research in sub-Saharan Africa, and increasing complexity in the range of ethical issues that need to be considered, is placing strains on many countries’ infrastructure for ethics review.

In Kenya, research ethics committees are accredited by the National Commission for Science, Technology and Innovation (NACOSTI), through its National Bioethics Committee. The number of accredited research ethics committees has increased from five in 2009 to 25 in 2018.

watermark

Through the STReK project, the University of Nairobi is working in collaboration with NACOSTI and the National Bioethics Committee to improve the efficiency of the Committee and to strengthen the capacity of members of both the National Committee and institutional research ethics committees in the country to undertake ethics review.

The project has facilitated the development of a new strategic plan for the National Bioethics Committee, based on extensive consultation among stakeholders. To support more effective working and streamlining of its operations, the project has helped to develop a set of revised standard operating procedures for the National Bioethics Committee. These will provide templates for use by research ethics committees across the country.

With support from the STReK project, the National Bioethics Committee is also enhancing its IT infrastructure for monitoring research ethics committees and creating a database of committee members to support networking and consultation. 

A research ethics training package is being developed and will be delivered to at least 120 committee members. A structured mentorship programme is also being introduced, including placements at mentor sites, for 22 research ethics committee members. At the end of the project, NACOSTI will organise a research ethics conference to promote networking, sharing of experience and benchmarking, with invitations extended to other national bioethics committees in East Africa and at least one EU research ethics committee.

The project

The later CHAPAS-3 trial compared the efficacy and safety of three fixed-dose combinations including two without stavudine (found to have some long-term side effects in adults, leading to a recommendation that its use be discontinued in children). The trial the first of its kind in Africa studied nearly 500 children at four sites in two African countries.

The STReK project is strengthening connections between academia and a key regulatory body in Kenya, to improve the efficiency and quality of ethics review processes in the country. It will help to ensure that the country remains an attractive country in which to carry out clinical research and has the capacity to increase the volume of research undertaken.

ratios forfixed-dose combinations and on appropriatedosage according to weight. 

The CHAPAS-3 trial confirmed the effectiveness of fixed-dose combinations, providing further impetus to the rollout of antiretrovirals to children. Its evidence on abacavir informed the WHO recommendation of abacavir-containing combinations for first-line therapy in children. Trial data have also been used to support applications for regulatory approval for new scored efavirenz tablets.

Impact

L’homme RF et al. Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets. AIDS. 2008;22(5):557–65.

Mulenga V et al. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIVinfected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Lancet Infect Dis. 2016;16(2):169–79.

WHO. Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2010.

WHO. Consolidated guidelines on the use of antiretroviral drugs
for treating and preventing

HIV infection: Recommendations for a public health approach
(second edition). 2016

Projects: Children with HIV in Africa Pharmacokinetics and Adherence of Simple Antiretroviral Regimens (CHAPAS): CHAPAS-1 and -3

Project lead: Professor Chifumbe Chintu, University Teaching Hospital, Zambia (CHAPAS-1); Dr Veronica Mulenga, University Teaching Hospital, Zambia (CHAPAS-3)

Target population(s): Children with HIV

Sample size: 71 (CHAPAS-1); 480 (CHAPAS-3)

Countries involved: Ireland, the Netherlands, the UK, the USA, Zambia (CHAPAS-1); Uganda, Zambia (CHAPAS-3)

Project duration: 2005–2009 (CHAPAS-1); 2010 –2011 (CHAPAS-3)

EDCTP funding: €1.2M (CHAPAS-1); €4.6M (CHAPAS-3)

Total project funding: €1.2M (CHAPAS-1); €5.0M